| Code | 6452E | ||||||||||
| MA number | EU/1/24/1813/001 | ||||||||||
| Product Form: | sol inj 1x1 ml/60 mg (striek.inj.napl.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Sandoz GmbH, Austria | ||||||||||
| Therapeutic Class: | 84 - VASOPRESSORICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(4) similar biological application |
| MA issued: | 16.05.2024 |
| Validity: | 16.05.2029 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Denosumab 60 mg_Karta pacienta.pdf
|
| Dokument: |
Denosumab 60 mg_Zoznam držiteľov.pdf
|
| Safety feature | Yes |
| Data update: | 30.05.2024 |
